Expanding genetic Horizons: GWAS insights from the VA Million Veterans Program

No­var­tis has again culled a late-stage tri­al of a bi­o­log­ic that it once thought could suc­ceed Xo­lair, its Genen­tech-part­nered an­ti-in­flam­ma­to­ry treat­ment for asth­ma and oth­er

The Rea­gan-Udall Foun­da­tion on Thurs­day pub­lished a wide-rang­ing re­port on how the FDA can com­bat mis­in­for­ma­tion, mark­ing some progress on one of FDA Com­mis­sion­er Robert